Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1034

    1.

    Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.

    Hu D, Hook EW 3rd, Goldie SJ.

    Ann Intern Med. 2004 Oct 5;141(7):501-13. Erratum in: Ann Intern Med. 2004 Nov 2;141(9):744. PMID: 15466767 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The cost effectiveness of opportunistic chlamydia screening in England.

    Adams EJ, Turner KM, Edmunds WJ.

    Sex Transm Infect. 2007 Jul;83(4):267-74; discussion 274-5.PMID: 17475686 [PubMed - indexed for MEDLINE]Related articles

    3.

    Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.

    Howell MR, Quinn TC, Gaydos CA.

    Ann Intern Med. 1998 Feb 15;128(4):277-84.PMID: 9471930 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

    Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, Freedberg KA.

    Ann Intern Med. 2006 Dec 5;145(11):797-806.PMID: 17146064 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia.

    Walleser S, Salkeld G, Donovan B.

    Sex Health. 2006 Dec;3(4):225-34.PMID: 17112432 [PubMed - indexed for MEDLINE]Related articles

    6.

    The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

    Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA.

    Ann Intern Med. 1999 Jan 19;130(2):97-107.PMID: 10068381 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women]

    Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Coutinho RA, Jager JC.

    Ned Tijdschr Geneeskd. 1999 Mar 27;143(13):677-81. Dutch. PMID: 10321301 [PubMed - indexed for MEDLINE]Related articles

    8.

    Visual screening for malignant melanoma: a cost-effectiveness analysis.

    Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, Freedberg KA.

    Arch Dermatol. 2007 Jan;143(1):21-8.PMID: 17224538 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis.

    Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Jager HC, Coutinho RA.

    Value Health. 2001 May-Jun;4(3):266-75.PMID: 11705188 [PubMed - indexed for MEDLINE]Related articles

    10.

    An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.

    Norman JE, Wu O, Twaddle S, Macmillan S, McMillan L, Templeton A, McKenzie H, Noone A, Allardice G, Reid M.

    BJOG. 2004 Nov;111(11):1261-8.PMID: 15521872 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

    Hutton DW, Tan D, So SK, Brandeau ML.

    Ann Intern Med. 2007 Oct 2;147(7):460-9.PMID: 17909207 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.

    Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M.

    Ann Intern Med. 2004 May 4;140(9):689-99.PMID: 15126252 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach.

    Welte R, Kretzschmar M, Leidl R, van den Hoek A, Jager JC, Postma MJ.

    Sex Transm Dis. 2000 Oct;27(9):518-29.PMID: 11034526 [PubMed - indexed for MEDLINE]Related articles

    14.

    The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies.

    Hu D, Hook EW 3rd, Goldie SJ.

    Sex Transm Dis. 2006 Jul;33(7):428-36.PMID: 16572038 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project.

    Roberts TE, Robinson S, Barton PM, Bryan S, McCarthy A, Macleod J, Egger M, Low N.

    BMJ. 2007 Aug 11;335(7614):291. Epub 2007 Jul 26.PMID: 17656504 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.

    Gift TL, Gaydos CA, Kent CK, Marrazzo JM, Rietmeijer CA, Schillinger JA, Dunne EF.

    Sex Transm Dis. 2008 Nov;35(11 Suppl):S66-75.PMID: 18830137 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.

    van Valkengoed IG, Postma MJ, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.

    Sex Transm Infect. 2001 Aug;77(4):276-82.PMID: 11463928 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.

    Kim JJ, Ortendahl J, Goldie SJ.

    Ann Intern Med. 2009 Oct 20;151(8):538-45.PMID: 19841455 [PubMed - indexed for MEDLINE]Related articles

    19.

    Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

    Shepherd J, Jones J, Takeda A, Davidson P, Price A.

    Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Developments in the screening for Chlamydia trachomatis: a review.

    Kohl KS, Markowitz LE, Koumans EH.

    Obstet Gynecol Clin North Am. 2003 Dec;30(4):637-58. Review.PMID: 14719842 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data